PR
PRENW
Prenetics Global Ltd
$0.0195
0.00%
No data for this timeframe.
Vol
SEC Reports7
Recent Activity
Jun 10, 2026
SEC
Prenetics Global (PRENW) filed its Q1 2026 6-K, reporting revenue of $36.0M, with IM8 revenue of $33.8M up 23.1% sequent
6-K — Impact 6/10
Jun 4, 2026
SEC
Prenetics appointed Hudson Leogrande, founder and CEO of the $1B+ DTC brand Comfrt, to its board as an independent direc
6-K — Impact 5/10
May 20, 2026
SEC
Prenetics Global Ltd announced a multi-year global partnership with Jay Shetty, naming him the first non-sport global am
6-K — Impact 6/10
Latest Reports
BULLISH
6-K
6/10
Prenetics Global (PRENW) filed its Q1 2026 6-K, reporting revenue of $36.0M, with IM8 revenue of $33.8M up 23.1% sequent
Jun 10, 2026
BULLISH
6-K
5/10
Prenetics appointed Hudson Leogrande, founder and CEO of the $1B+ DTC brand Comfrt, to its board as an independent direc
Jun 4, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
7 SEC filing reports analyzed. Sentiment: 6 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
BULLISH
6-K
6/10
Prenetics Global (PRENW) filed its Q1 2026 6-K, reporting revenue of $36.0M, with IM8 revenue of $33
Jun 10, 2026
BULLISH
6-K
5/10
Prenetics appointed Hudson Leogrande, founder and CEO of the $1B+ DTC brand Comfrt, to its board as
Jun 4, 2026
BULLISH
6-K
6/10
Prenetics Global Ltd announced a multi-year global partnership with Jay Shetty, naming him the first
May 20, 2026
NEUTRAL
6-K
3/10
Prenetics Global Ltd announced the appointment of Brian J. Rosin as CFO of its IM8 subsidiary, a pre
May 14, 2026
BULLISH
6-K
7/10
Prenetics reported preliminary Q1 2026 revenue of $36.0M (up 334.5% YoY from $8.3M), driven by IM8 r
May 14, 2026
BULLISH
6-K
6/10
Prenetics Global announces board authorization to divest its entire Bitcoin treasury (~510 BTC, expe
May 4, 2026
BULLISH
6-K
7/10
Prenetics has announced a strategic partnership with NBA superstar Giannis Antetokounmpo, who become
Apr 2, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 113.6% | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 126.0% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 110.4% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 57.7% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.